CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Teva Pharmaceuticals USA, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Teva Pharmaceuticals USA, Inc.
1090 Horsham Road
Phone: 215-591-3000p:215-591-3000 North Wales, PA  19454  United States Fax: 215-591-8600f:215-591-8600

This is a Subsidiary, click here for the Parent Company

Business Summary
Teva Pharmaceuticals USA, Inc. is engaged in the development, manufacture and marketing of generic and branded pharmaceuticals. The Company offers generic equivalents of prescription drugs in a wide variety of therapeutic categories, including cardiovascular, anti-inflammatory, anti-infective, oncology, central nervous system, and dermatological. Teva Select Brands manufactures and markets specialty medicines that include treatments for select metabolic, endocrine, and psychiatric disorders. Teva Women’s Health offers products including contraceptives and treatments for menopause and perimenopause. The Company operates as a subsidiary of Teva Pharmaceutical Industries Ltd.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
---Yes-Yes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--Yes--YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations

General Information
Fax Number: 215-591-8600


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024